HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-M Antibody Induced Prolonged Anemia Following Hemolytic Disease of the Newborn Due to Erythropoietic Suppression in 2 Siblings.

Abstract
Hemolytic disease of the newborn (HDN) arising from MNSs incompatibility is rare, with few reports of prolonged anemia and reticulocytopenia following HDN. We report the younger of 2 male siblings, both of whom had anti-M-induced HDN and anemia persisting for over a month. Peripheral reticulocytes remained inappropriately low for the degree of anemia, and they needed multiple red cell transfusions. Viral infections were ruled out. Corticosteroids were given for suspected pure red cell aplasia. Anemia and reticulocytopenia subsequently improved. Colony-forming unit erythroid assay revealed erythropoietic suppression of M antigen-positive erythroid precursor cells cultured with maternal or infant sera containing anti-M. In conclusion, maternal anti-M caused HDN and prolonged anemia by erythropoietic suppression in 2 siblings.
AuthorsAtsushi Ishida, Hitoshi Ohto, Hiroyasu Yasuda, Yutaka Negishi, Hideki Tsuiki, Takeshi Arakawa, Yoshihito Yagi, Daisuke Uchimura, Toru Miyazaki, Wataru Ohashi, Shigeru Takamoto
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 37 Issue 6 Pg. e375-7 (Aug 2015) ISSN: 1536-3678 [Electronic] United States
PMID25929611 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin M
  • Isoantibodies
Topics
  • Adult
  • Anemia (etiology, pathology)
  • Cell Differentiation
  • Colony-Forming Units Assay
  • Erythroblastosis, Fetal (etiology, pathology)
  • Erythroid Precursor Cells (immunology, pathology)
  • Erythropoiesis (immunology)
  • Female
  • Humans
  • Immunoglobulin M (blood, immunology)
  • Infant
  • Infant, Newborn
  • Isoantibodies (immunology)
  • Male
  • Pregnancy
  • Prognosis
  • Red-Cell Aplasia, Pure (complications)
  • Siblings

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: